New Release Genedata Screener Improves Strategy for High Throughput Screening Analysis
Genedata announces the release of Genedata Screener® 4.0, an open and scalable solution for high throughout screening (HTS) analysis. The software now boasts a well documented public application programming interface (API) and advanced procedures for analyzing high content screening data.
“We’ve created a powerful and straightforward strategy for validating data quality and pinpointing the most promising lead compounds”, says Dr. Michael Lindemann, Business Head Genedata Screener. The software handles high content screening data and consolidates Screener’s strengths in compound potency measurement using dose-response curve fitting.
New features include an API to link Screener’s database resources with the client’s existing corporate information portals. The release has new sorting and filtering capabilities that have been specially developed for lead discovery and compound validation.
“Screener 4.0 addresses recent moves in HTS towards cellular systems, biomolecular aspects of ADMET, and functional genomics”, explained Dr. Stephan Heyse, Project Head Genedata Screener. Genedata has honed its competencies in high content screening data analysis. It recently issued a joint statement with Evotec Technologies describing a high throughput solution for imaging screens. These features have been integrated into the 4.0 release.
Screener’s open architecture facilitates tight IT integration without costly customization. Dr. Lindemann added, “Our technologies bring benefit to focused screening campaigns in specific therapeutic areas as well as large scale screening operations”.
